Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(S)-2-(Phosphonoxy)caproyl-L-leucyl-p-nitroanilide is a synthetic small molecule and peptide derivative, structurally related to leucine. It is primarily used as an experimental inhibitor of peptide deformylase, an enzyme involved in the removal of the formyl group from the N-terminal methionine of newly synthesized proteins in bacteria. This compound has been studied for its ability to bind and inhibit bacterial peptide deformylase, making it a tool compound for structural biology and enzymology research rather than a therapeutic drug candidate[2][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on (S)-2-(phosphonoxy)caproyl-L-leucyl-p-nitroanilide.